Scholars Central

ArticlePublished 3 Oct 2024

Cryptotanshinone Suppresses Hepatic Stellate Cell Activation by Down-Regulating Janus Kinase 1/Signal Transducer and Activator of Transcription 3 Signalling Pathway

Authors: Huizhong Dong, Yaxin Tang, Fen Tang, Liang Zhao, Xin Dong, Si Chen

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Due to the absence of approved treatments, liver fibrosis remains a leading cause of liver cirrhosis and liver failure. Our previous study demonstrated that lipophilic constituents of Salvia miltiorrhiza Bunge can treat hepatic fibrosis by inhibiting hepatic stellate cells activation and regulating the janus kinase 1/signal transducer and the activator of the transcription 3 signaling pathway. However, specific active compounds in Salvia miltiorrhiza Labiatae sp that exert anti-fibrotic effects through this mechanism of action are yet to be identified. In this study, we treated and analyzed transforming growth factor beta-1-induced LX-2 and HSC-T6 cells with purchasable compounds in Salvia miltiorrhiza Labiatae sp via cell viability assays, which identified cryptotanshinone as an effective representative of Salvia miltiorrhiza Labiatae sp. Subsequent flow cytometry and western blot experiments revealed that cryptotanshinone could inhibit hepatic stellate cells activation by promoting apoptosis and reducing the expression of fibrosis markers such as transforming growth factor beta-1 and alpha-smooth muscle actin, along with downregulating the levels of janus kinase 1, phosphorylated-janus kinase 1 and signal transducer and the activator of the transcription 3 (p<0.05). Molecular docking studies further confirmed its binding affinity with janus kinase 1 and signal transducer and the activator of the transcription 3. This study provides a scientific basis for the application of Salvia miltiorrhiza Labiatae sp in the treatment of hepatic fibrosis and partially explains the pharmacological mechanism of cryptotanshinone against liver fibrosis.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Indian Journal of Pharmaceutical Sciences.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalIndian Journal of Pharmaceutical Sciences
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Huizhong Dong”
  • BylineArticles whose byline prints “Yaxin Tang”
  • BylineArticles whose byline prints “Fen Tang”
  • BylineArticles whose byline prints “Liang Zhao”
  • BylineArticles whose byline prints “Xin Dong”
  • BylineArticles whose byline prints “Si Chen”